LOW-DOSE ORAL METHOTREXATE TREATMENT OF MULTIPLE-SCLEROSIS - A PILOT-STUDY

被引:48
作者
CURRIER, RD
HAERER, AF
MEYDRECH, EF
机构
[1] UNIV MISSISSIPPI,MED CTR,DEPT PREVENT MED,JACKSON,MS 39216
[2] VET ADM MED CTR,JACKSON,MS
关键词
D O I
10.1136/jnnp.56.11.1217
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.
引用
收藏
页码:1217 / 1218
页数:2
相关论文
共 4 条
[1]   A NEW SCALE FOR EVALUATING DISABILITY IN MULTIPLE SCLEROSIS [J].
KURTZKE, JF .
NEUROLOGY, 1955, 5 (08) :580-583
[2]   THERAPEUTIC TRIAL OF IMMUNOSUPPRESSIVE AGENTS IN MULTIPLE-SCLEROSIS [J].
NEUMANN, JW ;
ZIEGLER, DK .
NEUROLOGY, 1972, 22 (12) :1268-+
[3]   LONG-TERM METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS [J].
SCULLY, CJ ;
ANDERSON, CJ ;
CANNON, GW .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 20 (05) :317-331
[4]  
WILKE WS, 1989, METHOTREXATE THERAPY